INAB In8Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INAB

Price (delayed)

$1

Market cap

$43.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1

Enterprise value

$26.9M

Highlights
In8Bio's quick ratio has increased by 44% from the previous quarter and by 27% YoY
In8Bio's equity has increased by 40% from the previous quarter and by 10% YoY
INAB's net income is down by 5% YoY
Sector: Healthcare
Industry: Biotechnology
Website: https://www.in8bio.com
Peers: OMER OMGA

Key stats

What are the main financial stats of INAB
Market
Shares outstanding
43.29M
Market cap
$43.29M
Enterprise value
$26.9M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.28
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$30.01M
EBITDA
-$27.51M
Free cash flow
-$23.94M
Per share
EPS
-$1
Free cash flow per share
-$0.8
Book value per share
$0.78
Revenue per share
$0
TBVPS
$1.13
Balance sheet
Total assets
$33.71M
Total liabilities
$8.77M
Debt
$4.89M
Equity
$24.94M
Working capital
$19.23M
Liquidity
Debt to equity
0.2
Current ratio
4.57
Quick ratio
3.95
Net debt/EBITDA
0.6
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-105%
Return on equity
-147.7%
Return on invested capital
-214.1%
Return on capital employed
-106%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INAB stock price

How has the In8Bio stock price performed over time
Intraday
-1.96%
1 week
-3.85%
1 month
-3.85%
1 year
-57.63%
YTD
-27.54%
QTD
-15.25%

Financial performance

How have In8Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$30.01M
Net income
-$30.01M
Gross margin
N/A
Net margin
N/A
INAB's operating income is down by 5% year-on-year
INAB's net income is down by 5% YoY

Growth

What is In8Bio's growth rate over time

Valuation

What is In8Bio stock price valuation
P/E
N/A
P/B
1.28
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 26% YoY and by 10% QoQ
In8Bio's equity has increased by 40% from the previous quarter and by 10% YoY
INAB's P/B is 33% below its last 4 quarters average of 1.9

Efficiency

How efficient is In8Bio business performance
The return on equity has declined by 45% year-on-year but it has grown by 3.3% since the previous quarter
In8Bio's ROIC has increased by 35% YoY but it has decreased by 4.6% from the previous quarter
The ROA has decreased by 28% YoY

Dividends

What is INAB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INAB.

Financial health

How did In8Bio financials performed over time
In8Bio's quick ratio has increased by 44% from the previous quarter and by 27% YoY
The company's current ratio rose by 29% QoQ and by 20% YoY
In8Bio's debt is 80% less than its equity
In8Bio's equity has increased by 40% from the previous quarter and by 10% YoY
In8Bio's debt to equity has decreased by 33% QoQ and by 23% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.